ZimVie on Aug. 10 reported net sales of $233.4 million in the second quarter.

AxioMed's artificial disc nears FDA approval and five more key updates from spine devicemakers since Aug. 3:

From robotic joint replacements to predicting pain outcomes, artificial intelligence is being used in a variety of ways in orthopedics.

Surgalign's artificial intelligence and augmented reality surgical guidance system, Holo Portal, debuted in the second quarter, and the devicemaker plans to grow its footprint by 2023.

Spine devicemaker Surgalign reported year-over-year revenue decreases in the second quarter and the first half of 2022, according to results posted Aug. 9.

NuVasive's executive vice president and chief commercial officer, Massimo Calafiore, is stepping down, the devicemaker said Aug. 9.

AxioMed completed the final steps toward FDA approval for its lumbar viscoelastic disc replacement device.

Alphatec posted significant year-over-year second-quarter growth and an increase in its surgeon user base, according to results posted Aug. 4.

Orthofix's second-quarter revenue fell compared to the same time last year across most of its business segments, according to results posted Aug. 5.

Becker's Spine Review has reported on three spine medtech companies settling disputes and conflicts since July 5.

Spineology's OptiLIF Endo system was released in a limited launch, the devicemaker said Aug. 4.

Devicemaker SpineNet named Bill McDonald the company's new COO.

Stryker on Aug. 3 opened a 156,000-square-foot additive manufacturing facility in Cork, Ireland, with the capacity to create 600 high-tech positions, according to the country's Industrial Development Agency.

NuVasive saw year-over-year increase in second-quarter revenue with $310.5 million, according to financial results posted Aug. 3.

Surgalign reached a $2 million settlement with the U.S. Securities and Exchange Commission related to activities between 2015 and 2019, the devicemaker said Aug. 3.

Conmed's multimillion-dollar acquisition and five more updates from spine and orthopedic devicemakers since July 27:

SeaSpine saw a 19 percent year-over-year increase in revenue during the second quarter of 2022, according to results posted Aug. 2.

Nevro Corp and Boston Scientific have reached an $85 million settlement in ongoing litigation over a spinal tech patent infringement.

Spinal devicemaker SeaSpine is launching an anterior lumbar interbody fusion device featuring the Reef A interbody.

Anders Cohen, DO, performed the first cast with Kleiner Device Labs' KG 2 Surge flow-through interbody system.